|
MECHANICAL
VENTILATION STRATEGIES
FOR
LUNG PROTECTION
Neil R. MacIntyre, MD
Duke University Medical Center
Durham, NC 27710
Presentation at
Conference May 1999
Wisconsin Society for Respiratory Care
Reprinted with Permission
OBJECTIVES:
1. Understand concept
of lung protection
2. Understand protective ventilatory
support strategies
3. Understand the results of various
clinical trials
4. Understand potential future
strategies
WHAT ARE WE PROTECTING THE LUNG FROM?
Numerous animal studies have shown that
the lung is subject to physical injury during mechanical ventilation
in two ways: a shear stretch injury from repeated opening and closing
of diseased alveoli and an over stretch injury induced by excessive
distention at end inspiration from the combination of the delivered
tidal stretch (VT) and
baseline stretch (PEEP). To minimize this injury potential, the first
goal is to provide enough PEEP to recruit the “recruitable”
alveoli while at the same time not applying so much PEEP that
healthier regions are unnecessarily overdistended. The second goal is
to avoid a PEEP/VT combination that unnecessarily overdistends lung
regions at end inspiration, generally reflected by elevations in
plateau pressure (end inspiratory alveolar pressure) above
approximately 35 cm H2O. Better estimates of lung mechanical
properties might be obtained by static pressure volume (PV) curves and
these might be further enhanced by using esophageal/pleural pressures
to account for any chest wall abnormalities that may be present.
Unfortunately, clinical monitors to easily and reliably make these
static PV measurements are not widely available.
STRATEGIES FOR LUNG PROTECTION
Modes.
Generally, severe respiratory failure is managed during the acute
phases with an assist control mode of ventilation (ACV). This assures
that all breaths have positive pressure supplied by the ventilator to
provide virtually all of the work of breathing. The assist
capabilities of ACV allow the patient to trigger breaths. This may
help in controlling CO2 and improving patient comfort. If an
inappropriate respiratory drive exists or patient triggering of
assisted breaths is uncomfortable, sedation and/or paralysis may be
needed such that only the control breaths of ACV are provided. It
should be remembered, however, that unless the patient is grossly dys-synchronous
with the ventilator despite every effort to make the assisted breaths
comfortable, paralysis to eliminate muscle activity should be avoided.
Similarly, strategies that routinely employ paralysis and controlled
ventilation to reduce oxygen consumption (V02) should also be avoided
as the potential decrease in V02 is generally small and the risk of
long term myopathy is substantial.
Choosing pressure vs. volume targeted
ventilation for total support depends upon the clinical situation.
Volume targeted ventilation (volume assist-control ventilation - VACV)
guarantees a certain tidal volume. This, in turn, gives clinician
control over minute ventilation and CO2 clearance. Under these
conditions, however, airway and alveolar pressures are dependent
variables and will rise or fall depending upon changes in lung
mechanics or patient effort. Sudden worsening of compliance or
resistance can, thus, cause abrupt increases in airway and alveolar
pressures. Pressure targeted ventilation, on the other hand, does not
guarantee volume but rather controls airway pressure. Volume is thus a
dependent variable and will change as lung mechanics or patient
efforts change. Sudden worsening of compliance or resistance with
pressure targeted ventilation results in a loss of volume. Pressure
targeted ventilation also has a variable decelerating flow wave form
which may improve gas mixing and may interact with any patient efforts
more synchronously.
The choice of pressure vs volume
targeted breaths depends on which feature is required for the clinical
goal. Specifically, if CO2 clearance is of primary concern and patient
comfort and lung stretch are less of an issue (e.g., mild lung injury
with a cerebral mass lesion), volume targeted ventilation would be
preferable. On the other hand, if over distention risk is high and/or
patient synchrony is more of an issue the CO2 clearance (e.g., severe
ARDS with normal cardiac and neurologic function) pressure targeted
ventilation is probably the correct choice. There are several
ventilator modes that offer pressure targeting and volume cycling
features. While these modes do offer the decelerating wave form of
pressure targeted breaths and thus may help patient comfort and gas
mixing, the volume guarantee means that pressure must increase if lung
mechanics worsen. Thus, while these breaths in these modes have
pressure targeting features, they are not pressure limiting.
Frequency-tidal volume settings.
The tidal breath, in conjunction with the baseline pressure, should be
set in such a way that the plateau pressure is < 35 cm H2O (or some
other index of over distention does not occur). Generally, this
involves tidal volumes (VT) of 8-10 ml/kg although VT as low as 5-6
ml/kg may be needed. Older strategies of using higher tidal volumes
arose from a need to prevent atelectasis. Now that PEEP strategies are
better understood and the risk of over distention better appreciated,
this need has lessened.
The set ventilator frequency is
generally used to control the CO2. A reasonable starting point is a
normal frequency of between 12 and 20 breaths per minute. Increasing
the frequency will increase minute ventilation and generally will
increase CO2 clearance. At some point, however, air trapping will
develop because of inadequate expiratory times. Under these
conditions, minute ventilation will either start to fall off (pressure
targeted ventilation) or airway pressures will start to rise (volume
targeted ventilation). In general, this begins to happen at breathing
frequencies of approximately 35 breaths per minute although it can
occur at much lower frequencies if the inspiratory to expiratory ratio
is high or the time constant for lung emptying (resistance x
compliance) is very high.
PEEP/FiO2.
The goal of PEEP therapy is to recruit “recruitable” alveoli while
not over distending already patent alveoli. PEEP performs its
recruitment action primarily by preventing the deflation and collapse
of an alveoli opened by a tidal breath. This may be enhanced by
performing a volume recruitment maneuver consisting of 1-2 minutes of
PEEP values in the 15-25 cm H2O range and then returning to an optimal
setting as described below. In determining the ultimate optimal
setting, two basic approaches exist that use either mechanical
criteria or gas exchange criteria.
Mechanical criteria involve assessments
that attempt to insure that PEEP recruits “recruitable” alveoli
but not over distends alveoli already recruited. Two approaches have
been reported: 1) Use pressure volume curves to set the PEEP/VT
combination between the upper and lower inflection points. A
modification of the conventional static approach uses a very slow
inspiratory flow and then measures upper and lower inflection points
from the resulting dynamic pressure volume curves. As noted above,
using an esophageal pressure to account for chest wall mechanic
enhances these techniques. 2) Use step increase in PEEP to determine
the PEEP level that gives the best compliance.
Gas exchange criteria to guide PEEP
application involve several potential strategies. One approach would
be to do a PEEP titration curve (after a volume recruitment maneuver -
see above) to determine the lowest Fi02 that could be achieved.
Another approach would be to use algorithms designed to provide
adequate values for Pa02 while minimizing FiO2. Note that constructing
a PEEP/Fi02 algorithm is usually an empirical exercise in balancing
Sa02 with Fi02 and depends upon the clinician’s perception of the
relative “toxicities” of high thoracic pressures, high Fi02 and
low Sa02.
In general, commonly used “operational”
ranges for PEEP in parenchymal lung injury are 5 - 25 cm H20. However,
some argue that, at least in the initial phases of lung injury, the
range should be higher (eg., 12 - 25 cm H20) and that a volume
recruitment maneuver should be performed to assure optimal
recruitment. With this approach, PEEP would only be weaned when the
Fi02 is £ 0.4.
Inspiratory : expiratory timing.
Setting the inspiratory time and the inspiratory to expiratory ratio (I:E)
involves several considerations. The normal I:E ratio is roughly
1:2-1:4. This produces the most comfort and thus is the usual initial
setting. Assessment of the flow graphic should also be done to insure
that an adequate expiratory time is present to avoid air trapping.
Inspiratory expiratory (I:E)
prolongation beyond the physiologic range of 1:2 to 1:4 can be
employed as an alternative to increasing PEEP to improve V/Q matching
in severe respiratory failure. Generally, inspiratory time
prolongation is reserved for patients in whom the plateau pressure
from the PEEP/tidal volume combination has approached 35 cm H2O and
potentially toxic concentrations of FiO2 are being employed without
meeting Sa02 on or oxygen delivery goals. Inspiratory time
prolongation has several important physiologic effects. First, a
longer inspiratory time results in a longer alveolar - conducting
airway gas mixing time. Second, a longer inspiratory time can give
slower filling alveolar units time to be ventilated and recruited.
Finally, if expiratory time is inadequate for lung emptying, air
trapping and intrinsic PEEP can develop. A number of studies have
shown improved gas exchange as a consequence of longer inspiratory
times but sorting out which physiologic mechanism is responsible is
not clear. Indeed, long inspiratory times without air trapping have
been shown in one study to improve PaO2 while others have argued that
improved PO2 occurs only as a consequence of PEEPi development.
Several other aspects of long
inspiratory times strategies need to be considered when using this
technique. First, the development of air trapping has different
effects on pressure vs. volume targeted ventilation. Second, although
long inspiratory times are often used with pressure controlled breaths
to utilize the rapid initial flow pattern and the pressure limit
feature, long inspiratory time strategies have also been used with
volume targeted breaths, generally by adding an inspiratory pause.
Third, long inspiratory time will increase mean airway pressure and
thus can reduce cardiac filling. Moreover, in the presence of air
trapping, the mean alveolar pressure will be higher than the mean
airway pressure making monitoring of intrathoracic pressure more
difficult. Fourth, lengthening the inspiratory to expiratory ratio
beyond 1:1 is also quite uncomfortable and usually requires heavy
sedation and/or paralysis.
One approach to using long inspiratory
time strategies would avoid air trapping. The rationale behind this
approach is to use longer inspiratory times for their mixing and
filling effects but not to produce PEEPi. This is because there is no
evidence that intrinsic PEEP produces any better improvement in V/Q
matching than extrinsic or applied PEEP. Moreover, intrinsic PEEP may
be more pronounced in lung regions with airway dysfunction and good
compliance as compared to the stiff alveolar regions that require
recruitment.. This contrasts with applied PEEP which is more
homogeneously distributed. Another reason to avoid air trapping and
intrinsic PEEP with long inspiratory time strategies is because of
their effects on desired ventilator settings noted above.
EVIDENCE THAT LUNG PROTECTIVE
STRATEGIES ARE EFFECTIVE
The original clinical trial that
introduced this concept was that of Hickling et al. They used
historical controls to illustrate that a mechanical ventilator
strategy designed to limit maximal distension in severe lung injury
could improve mortality. They concluded that the benefits of a lung
“protective” ventilator support strategy were worth the tradeoff
of a substantial respiratory acidosis.
In the last 5 years, 4 large clinical
trials have been conducted to address this issue. Three have been
published. The patient selection criteria, ventilator strategies, and
important outcomes from those which have been published are summarized
in Table 1.
(Editorial note: Information about the
4th trial, a NIH ARDS Network
trial, has been deleted from this article as on March 15, 1999 the NIH
issued a press release stating that the clinical trial was stopped
early because of significant positive clinical results for lung
protection. This NIH Press Release is available as a separate article
in this section of the ARDS Support Center website.)
TABLE 1
| |
TREATED |
|
|
|
CONTROL |
|
|
| |
Brochard |
Stewart |
Amato |
|
Brochard |
Stewart |
Amato |
| |
|
|
|
|
|
|
|
|
Apache |
17 |
21 |
27 |
|
19 |
22 |
28 |
|
Failed Organs |
1.3 |
2.7 |
|
|
1.4 |
2.6 |
|
| |
|
|
|
|
|
|
|
|
Vt |
721 |
700 |
738 |
|
497 |
475 |
387 |
|
Pplat |
32 |
28 |
38 |
|
26 |
21 |
24 |
|
PEEP |
11 |
8 |
9 |
|
11 |
9 |
13 |
|
P/F |
141 |
146 |
|
|
134 |
239 |
|
|
PCO2 |
41 |
45 |
35 |
|
59 |
54 |
51 |
|
Day 28 Mort |
32 |
47 |
71 |
|
37 |
50 |
38 |
Note from the Table that one study
shows benefit from a lung “protective” strategy while the other
two do not. There are two important points to be made about these 3
studies, however: First, only the study in which the control group had
potentially “toxic” overdistension pressures showed benefit from a
low distension strategy. Second, this same study showing benefit also
used much higher PEEP levels in the lung “protective” group.
FUTURE PROTECTIVE LUNG STRATEGIES
Potential respiratory support
strategies that might enhance lung protection include:
1. High frequency ventilation.
By providing low maximal pressures and high recruitment pressures, HFV
might be the "ultimate" lung protective strategy for a
positive pressure ventilatory support system.
2. Partial liquid ventilation. An
oxygen soluble flurocarbon can be used to provide alveolar recruitment
and improved lung mechanics.
3. Surfactant replacement.
When instilled in large quantities, surfactant (along with surfactant
related proteins) can improve lung mechanics.
4. NO.
Nitric oxide is a pulmonary vasodilator that may spare the lung from
unneccessary O2 exposure.
5. ECMO.
Extracorporeal systems can reduce (or eliminate) the need for positive
REFERENCES
1. Slutsky AS. ACCP Consensus
Conference: Mechanical Ventilation. Chest, 1993; 104:1833-1859.
2. Fiehl F, Perret C. Permissive
hypercapnia - how permissive should we be? Am J Resp Crit Care Med
150: 1722-1737, 1994.
3. Hickling KG, Walsh J, Henderson S,
Jackson R. Low mortality rate in adult respiratory distress syndrome
using low-volume, pressure-limited ventilation with permissive
hypercapnia: a prospective study. Crit Care Med 22: 1568-1578, 1994.
4. Kolobow T, Moretti MP, Fumagalli R
et al. Severe impairment in lung function induced by high peak airway
pressure during mechanical ventilation. Am Rev Resp Dis 135:312-315,
1987.
5. American Association for Respiratory
Care. Positive End Expiratory Pressure - State of the art after 20
years. Resp Care 1988; 33:417-500.
6. Amato, MB, Barbas CSV, Medeivos DM,
et al. Effect of a Protective-Ventilation Strategy on Mortality in the
Acute Respiratory Distress Syndrome. N Engl J Med 1998; 338:347-54.
7. Servillo, G, Svantesson, C, Beydon,
L, Roupie, E et al. Pressure-volume curves in acute respiratory
failure: automated low flow inflation vs occlusion. Am J Resp Crit
Care Med, 1997; 155: 1629-36.
8. Suter PM, Fairley HB, Isenberg MD.
Optimum end-expiratory pressure in patients with acute pulmonary
failure. N Engl Med 1975; 292:284-289.
9. Cole AGH, Weller SF, Sykes MK.
Inverse ratio ventilation compared with PEEP in adult respiratory
failure. Intensive Care Medicine 1984; 10:227-232.
10. Tharratt RS, Allen RP, Albertson
TE. Pressure controlled inverse ratio ventilation in severe adult
respiratory failure. Chest 94: 755-62, 1988.
11. Armstrong, BW, MacIntyre, NR.
Pressure controlled inverse ratio ventilation that avoids air trapping
in ARDS. Crit Care Med 1995; 23:279-285.
12. Anzueto A, Baughman RP, Guntapalli
KK, Weg JG et al. Aerosolized surfactant in adults with sepsis induced
ARDS. New Engl J. Med 1996; 334:1417-1421.
|